This report describes validation of claims-based frailty algorithms for potential use in Medicare claims.
Related Products:
Public Health
Access up-to-date ASPE research on key public health topics including emerging and re-emerging infectious diseases, such as influenza and COVID-19; health equity; antibiotic resistance; rural health; opioids, opioid use disorder and overdose prevention; maternal health; public health and health care workforce and infrastructure; immunization and vaccines; Indian health; HIV/AIDS; tobacco; and emergency preparedness, response, and recovery. Also find data on prevention, social determinants of health, and more.
Noteworthy
HHS Initiative to Improve Maternal Health
The Department’s Action Plan lays out a vision for improving maternal health that applies a “life course” approach organized around four goals and it sets three ambitious targets to achieve this vision. Each of the four goals includes multiple objectives and action items to drive progress. The Action Plan also describes the current state of maternal health outcomes in the U.S., challenges in reducing maternal mortality and morbidity, recent efforts to improve maternal health within and beyond the federal government, and it discusses various forums in which HHS leadership sought input from key stakeholders.
Reports
Displaying 71 - 80 of 962. 10 per page. Page 8.
Advanced SearchReport
Reviewing, Refining, and Validating Claims-Based Algorithms of Frailty and Functional Impairment
Report, Research Summary
EHR Implementation Guide – Identifying Frailty Using Existing Health Data: Challenges and Opportunities for Health Systems
RAND identified use cases on identifying frailty using electronic health record (EHR) data in health systems in the US and examples from other countries, which demonstrate applications in both primary and specialist care. The final EHR implementation guide summarizes the learnings from participants in the EHR Learning Network and the identified use cases.
Report
Surging the Public Health Workforce: Lessons Learned from the COVID-19 Response at State, Tribal, Local, and Territorial Public Health Agencies
The Office of the Assistant Secretary for Planning and Evaluation (ASPE) released a report summarizing lessons learned from surging the governmental public health workforce at state, tribal, local, and territorial (STLT) public health agencies during the COVID-19 pandemic.
ASPE Issue Brief
Medicaid HCBS State Policy Flexibilities During COVID
During the COVID-19 public health emergency, states used Appendix K, a standalone appendix available during emergency situations, to modify their existing Medicaid HCBS 1915(c) waiver programs. Using Appendix K, states can make to make temporary changes to access and eligibility, payment, services, and other aspects of their waiver programs.
ASPE Issue Brief, Report
Direct Care Worker Wages
Direct care workers (DCWs) such as nursing assistants, home health aides, and personal care assistants play an essential role in the health and well-being of over 20 million Americans. Yet DCW wages are not enough to make jobs competitive with entry level positions in other industries with similar job requirements which exacerbates the challenges in recruitment and retention of these workers.
ASPE Issue Brief
Understanding Markets for Antimicrobial Drugs
Development of novel antimicrobials has slowed, and the preclinical and clinical pipeline is likely to be insufficient to support current and future patient needs.
Report
Emergency Department Interventions for Opioid Use Disorder
Emergency departments (EDs) are key partners in filling the gap between people who need opioid use disorder (OUD) treatment and people who ultimately receive it.
Report
Analysis of Market Challenges for Antimicrobial Drug Development in the United States
The market for antimicrobial (AM) drugs is unique in that it is associated with a positive externality (public health) as well as a negative externality (antimicrobial resistance, or AMR) (Mossialos, et al., 2010). AMR occurs when microbes change over time and no longer respond to available medicine.
Report
Antimicrobial Drugs - Burden of Antimicrobial Resistance
It is well known that antimicrobial resistance (AMR) creates a substantial and ongoing public health and economic burden and understanding the size and nature of this burden is important for the ability to respond to the threat of AMR. However, estimating or projecting that burden within the U.S.
Report
Antimicrobial Drugs - Market Returns Analysis
In 2017, at least 2.8 million people in the U.S. acquired serious infections with bacteria that are resistant to one or more antimicrobial drugs and 35,000 have died as a result. Resistance to antimicrobials is viewed as a global threat with antimicrobial drug use in human and animal health driving resistance.